Transdermal Scopolamine Market is poised to reach a valuation of US$585.3 mn by 2024

A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the arena will remain low over the forthcoming years. “The leading participants are focusing towards acquiring small companies in order to consolidate their position in the market,” says the author of the report.

The opportunity in the global transdermal scopolamine market was pegged at US$330.0 mn in 2015 and is poised to reach a valuation of US$585.3 mn by the end of 2024, progressing at a healthy CAGR of 6.70% between 2016 and 2024.

Read Report Overview: https://www.transparencymarketresearch.com/transdermal-scopolamine-market.html

North America to Stay Ahead through 2024, thanks to Robust Healthcare Facilities

Geographically, North America will continue to be at the forefront of the growth of the global market for transdermal scopolamine until 2024. The presence of an advanced healthcare infrastructure along with the increasing consumer healthcare spending is acting as the primary factor driving the regional market. The market in North America is witnessing increased usage of transdermal scopolamine in surgeries and post-operative treatments. However, the growth of the region is impeded by the limited availability of generics. Owing to these factors, the region will exhibit a CAGR of 6.40% during the forecast period.

Europe and Asia Pacific are expected to register strong growth during the same period. The growth of Europe can be attributed to the widening pool of travelers and the presence of a state-of-art healthcare industry.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22322

Increasing Number of Surgeries Performed Worldwide to Stir up Uptake of Transdermal Scopolamine

The global market for transdermal scopolamine is gaining significant momentum, thanks to the increasing awareness among consumers regarding its high effectiveness in treating motion sickness. The growing number of travelers worldwide are, therefore, shot in the arm for the global market. “Transdermal scopolamine is also being increasingly used in surgeries as it aids in controlling hyper salivation and helps in recovering from anesthesia-induced and postoperative vomiting and nausea,” says a TMR analyst. Hence, the dramatic rise in the number of people undergoing surgeries every year is reflecting positively on the global sales of transdermal scopolamine patches. Researchers anticipate that the market will continue to post phenomenal growth in the coming years as well.

Side-effects of Transdermal Scopolamine to Limit their Widespread Adoption

On the flip side, the upward growth of the market is marred by the side-effects caused by the consumption of these patches, such as retarded motion, drowsiness, and diluted pupils. Besides this, the rising reporting of cases of adverse withdrawal symptoms for these patches and the presence of stringent rules and regulations pertaining to the manufacturing and marketing of these products are limiting the global transdermal scopolamine market from realizing its utmost potential.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22322

Nevertheless, emerging countries are expected to offer lucrative growth opportunities. The proliferation of small- and medium- scale players in developing regions is boosting the scope of market expansion. The improving healthcare sector and booming medical tourism are providing the immense potential to these countries, which in turn is likely attract the attention of key global players.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.